The brain-gut-axis is an interdependent system affecting neural functions and controlling our eating behaviour. In recent decades, neuroimaging techniques have facilitated its investigation. We systematically looked into functional and neurochemical brain imaging studies investigating how key molecules such as ghrelin, glucagonlike peptide-1 (GLP-1), peptide tyrosine-tyrosine (PYY), cholecystokinin (CCK), leptin, glucose and insulin influence the function of brain regions regulating appetite and satiety.
Introduction
The brain-gut axis is an interdependent system that affects neural function and controls our eating behaviour through biochemical signalling between the endocrine and nervous system through hormonal peptides in the gastrointestinal tract (Huda et al., 2006; Steinert et al., 2017; Wren and Bloom, 2007) . The two main families of gastrointestinal (GI) hormones are a) Appetite stimulators, such as ghrelin, a 28 amino acid peptide that promotes meal initiation by increasing appetite and hunger feelings (Cummings et al., 2001; Kojima et al., 1999) , and b) Satiety stimulators, such as the gut hormones glucagon-like peptide-1 (GLP-1), peptide tyrosine tyrosine (PYY3-36) cleaved from PYY1-36, cholecystokinin (CCK) and leptin that signal the brain to decrease hunger and promote meal cessation (Figlewicz, 2003; Woods et al., 1998) . Next to these GI hormones, insulin, a pancreatic hormone, as well as insulin regulated glucose, play a major role in human metabolism and eating behaviour (Figlewicz, 2003; Woods et al., 1998) .
Neuroimaging techniques have greatly facilitated the investigation of human brain-gut interactions in recent decades. Pioneering studies combining functional magnetic resonance imaging (fMRI) with hormonal blood analyses have demonstrated a direct link between changes in plasma concentrations in hormones and modifications in brain regions that are part of the neural circuit of appetite, as identified by Woods et al. (1998) . In particular, increased insulin plasma levels are linked to changes in brain activity in the anterior cingulate cortex (ACC), in the orbitofrontal cortex (OFC), in the sensorimotor cortex and in the hypothalamus. On the other hand, it is well established that ghrelin acts through the hypothalamus to influence several brain regions involved in the foodreward pathway, including the ventral tegmental area (VTA), nucleus accumbens, amygdala, and hippocampus (Abizaid et al., 2006; Diano et al., 2006; Nakazato et al., 2001 ). These findings suggest that different gut peptides divergently modulate brain activation in the neural circuit controlling appetite and thereby regulate our prospective eating behaviour.
However, studies often report inconsistent findings making a general interpretation difficult. There are different reasons for the discrepancies: study designs have been variable with different nutrients ingested (stimulating different gut peptides) and different paradigms have been used during fMRI examination.
A general overview of the different studies and of the methodologies used in the field is therefore necessary.
In the present study, we systematically reviewed functional and neurochemical brain imaging studies investigating how the main gut peptides (ghrelin, PYY3-36, leptin, GLP-1 and CCK), insulin and glucose influence activation in brain regions regulating appetite and satiety in healthy and obese subjects. On the basis of the findings of these studies, we hypothesised that the brain areas involved in the food-reward circuit, such as the anterior cingulate cortex (ACC), the insula and the hypothalamus, are activated in opposite directions, by gut peptides linked to satiety or to appetite stimulation.
Methods
To ensure high quality reporting, PRISMA guidelines for systematic reviews were followed (Moher et al., 2015) .
Search strategy
An electronic search was performed using the PubMed database. The following search terms were used: ((ghrelin OR glucose OR insulin OR peptide YY OR leptin OR GLP-1 OR cholecystokinin) AND (appetite OR satiety)) AND (mri OR fmri OR pet OR spect OR imaging OR neuroimaging). All studies published before July 2016 were included, D. Zanchi et al. Neuroscience and Biobehavioral Reviews 80 (2017) [457] [458] [459] [460] [461] [462] [463] [464] [465] [466] [467] [468] [469] [470] [471] [472] [473] [474] [475] without any language restriction. Additionally, the reference lists of all included studies identified in the database search were manually screened for relevant studies.
Selection criteria and study selection
The review included original publications in peer reviewed journals, observational or interventional study designs and applications of functional or neurochemical neuroimaging techniques. All the included articles used a randomised double-blinded placebo-controlled design. Based on previous studies and on the existing literature (Huda et al., 2006; Jenkins et al., 1987; Wren and Bloom, 2007) , one gut peptide regulating appetite (ghrelin) and four regulating satiety (peptide YY, leptin, GLP-1, CCK), as well as insulin and glucose, were investigated. The current review focuses on how changes in plasma concentration of gut hormones result in modifications of brain functions regulating appetite and satiety.
After inspection for duplicates, the titles and abstracts of all records were reviewed. Publications that clearly did not meet inclusion criteria were excluded. The decision for inclusion or exclusion of the remaining publications was made on the basis of a review of the full texts. The whole process was independently conducted by two reviewers (DZ, SB). In case of disagreement, reviewers discussed their reasons for initial inclusion and exclusion. If consensus was not reached, a third reviewer (AS) was included.
Recorded variables, data extraction and analysis
The recorded variables for each article included in the review were: authors and year of publication, study design, assessed peptides, administered substance, amount of nutrient received, modality of administration, imaging method, number of healthy subjects, number of obese subjects, gender distribution, age, Body max index (BMI), brain region investigated, analysed brain regions, statistical thresholds and main findings. If overlaps between subjects were suspected but the original publications did not contain information on that topic, we contacted the authors and included the obtained data in the review.
Results

Identified studies
Of 343 publications found in the PubMed database and 6 articles identified in the reference lists, 40 articles were included in this review.
244 publications did not meet the inclusion criteria (e.g. animal models, case reports, review articles, pathological conditions) and were thus excluded. 66 studies were excluded since they investigated appetite without including any brain examination or hormone administration.
A flowchart of the selection procedure, with the included and excluded studies, is shown in Fig. 1. 
Study characteristics
Of the 40 included articles, 17 studies used fMRI with a "food-cue paradigm" De Silva et al., 2011; Douglas et al., 2015; Goldstone et al., 2014; Grosshans et al., 2012 Heni et al., 2014 Hinkle et al., 2013; Karra et al., 2013; Kroemer et al., 2013a Kroemer et al., ,b, 2015 Leidy et al., 2013; Malik et al., 2008; Page et al., 2011; Rosenbaum et al., 2008; Wallner-Liebmann et al., 2010) , eleven an "on-off treatment related block design" Eldeghaidy et al., 2016; Jones et al., 2012; Lassman et al., 2010; Li et al., 2012; Little et al., 2014; Liu et al., 2000; Purnell et al., 2011; Spetter et al., 2014; Sun et al., 2014) , five a resting state fMRI (rsfMRI) paradigm Page et al., 2013; Wölnerhanssen et al., 2015; Wright et al., 2016; Zhang et al., 2015) and five studies an fMRI-ASL (arterial spin labelling) sequence (two studies used both rsfMRI and ASL) Lennerz et al., 2013; Page et al., 2009 Page et al., , 2013 Schilling et al., 2014) . Four were neurochemical imaging studies using positron emission tomography (PET) Pannacciulli et al., 2007; Savage et al., 2014; Tataranni et al., 1999) .
All included studies were published between 2007 and 2016. 13 studies investigated the effect of the appetite-stimulating hormone ghrelin Goldstone et al., 2014; Jastreboff et al., 2016; Jones et al., 2012; Kroemer et al., 2013a Kroemer et al., ,b, 2015 Leidy et al., 2013; Li et al., 2012; Malik et al., 2008; Savage et al., 2014; Sun et al., 2014 Sun et al., , 2015 , while 30 studies investigated the impact of satiety-inducing hormones and glucose van Bloemendaal et al., 2014; De Silva et al., 2011; Douglas et al., 2015; Eldeghaidy et al., 2016; Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014 Heni et al., , 2015 Hinkle et al., 2013; Jastreboff et al., 2016; Kroemer et al., 2013b Kroemer et al., , 2015 Leidy et al., 2013; Lennerz et al., 2013; Li et al., 2012; Liu et al., 2000; Page et al., 2009 Page et al., , 2011 Page et al., , 2013 Pannacciulli et al., 2007; Purnell et al., 2011; Rosenbaum et al., 2008; Schilling et al., 2014; Spetter et al., 2014; Tataranni et al., 1999; Wallner-Liebmann et al., 2010; Wölnerhanssen et al., 2015; Wright et al., 2016; Zhang et al., 2015) . Eight studies focused on glucose Heni et al., 2014; Lennerz et al., 2013; Purnell et al., 2011; Wallner-Liebmann et al., 2010; Wright et al., 2016) , 15 on insulin Gautier et al., 2000; Heni et al., 2014; Jastreboff et al., 2016; Kroemer et al., 2013a; Lennerz et al., 2013; Li et al., 2012; Liu et al., 2000; Page et al., 2009 Page et al., , 2013 Schilling et al., 2014; Tataranni et al., 1999; Wallner-Liebmann et al., 2010; Wölnerhanssen et al., 2015; Zhang et al., 2015) , four on peptide YY De Silva et al., 2011; Douglas et al., 2015; Leidy et al., 2013) , five on leptin Hinkle et al., 2013; Jastreboff et al., 2016; Kroemer et al., 2015; Rosenbaum et al., 2008) , five on GLP-1 Douglas et al., 2015; Heni et al., 2015, p. 2; Li et al., 2012; Pannacciulli et al., 2007) and four on CCK Lassman et al., 2010; Li et al., 2012; Little et al., 2014) .
To assess brain changes associated with these gut peptides, a broad variety of nutrients with extensive differences in protein load were administered. In 16 studies, subjects directly received the target nutrient (such as glucose) De Silva et al., 2011; Eldeghaidy et al., 2016; Heni et al., 2014 Heni et al., , 2015 Hinkle et al., 2013; Jones et al., 2012; Kroemer et al., 2013a,b; Little et al., 2014; Malik et al., 2008; Page et al., 2009 Page et al., , 2011 Page et al., , 2013 Rosenbaum et al., 2008; Schilling et al., 2014) , while in 24 studies subjects consumed standardised meals (containing for instance: fibres, soy or chocolate milkshake) with different amounts of protein Douglas et al., 2015; Gautier et al., 2000; Goldstone et al., 2014; Grosshans et al., 2012; Jastreboff et al., 2016; Karra et al., 2013; Kroemer et al., 2015; Lassman et al., 2010; Leidy et al., 2013; Lennerz et al., 2013; Li et al., 2012; Liu et al., 2000; Pannacciulli et al., 2007; Purnell et al., 2011; Savage et al., 2014; Schilling et al., 2014; Spetter et al., 2014; Sun et al., 2014 Sun et al., , 2015 Tataranni et al., 1999; WallnerLiebmann et al., 2010; Wright et al., 2016; Zhang et al., 2015) .
As regards the modality of administration, 12 studies used an intravenous canula (Figlewicz, 2003; Goldstone et al., 2014; Grosshans et al., 2012; Heni et al., 2014; Hinkle et al., 2013; Karra et al., 2013; Kojima et al., 1999; Liu et al., 2000; Nakazato et al., 2001; Spetter et al., 2014; Sun et al., 2015) , in 22 studies the substances were ingested orally Eldeghaidy et al., 2016; Gautier et al., 2000; Heni et al., 2014 Heni et al., , 2015 Jastreboff et al., 2016; Karra et al., 2013; Kroemer et al., 2013a Kroemer et al., , 2015 Leidy et al., 2013; Lennerz et al., 2013; Li et al., 2012; Little et al., 2014; Liu et al., 2000; Page et al., 2013; Pannacciulli et al., 2007; Schilling et al., 2014; Spetter et al., 2014; Sun et al., 2014 Sun et al., , 2015 Tataranni et al., 1999; Wright et al., 2016; Zhang et al., 2015) , in three studies a nasogastric tube was used (Lassman et al., 2010; Spetter et al., 2014; Wölnerhanssen et al., 2015) , while in three studies no administration was performed Savage et al., 2014; Wallner-Liebmann et al., 2010) . The time between nutrient administration and brain imaging examination varied as well: in 14 studies, the neuroimaging examination started immediately after nutrient administration van Bloemendaal et al., 2014; Douglas et al., 2015; Gautier et al., 2000; Jastreboff et al., 2016; Jones et al., 2012; Lassman et al., 2010; Li et al., 2012; Malik et al., 2008; Page et al., 2013 Page et al., , 2011 Purnell et al., 2011; Spetter et al., 2014; Zhang et al., 2015) , while in the other 20 brain signals were recorded 5-120 min after nutrient administration Eldeghaidy et al., 2016; Gautier et al., 2000; Goldstone et al., 2014; Heni et al., 2014 Heni et al., , 2015 Karra et al., 2013; Kroemer et al., 2013a,b; Lennerz et al., 2013; Little et al., 2014; Page et al., 2009; Pannacciulli et al., 2007; Schilling et al., 2014; Sun et al., 2014 Sun et al., , 2015 Tataranni et al., 1999; Wölnerhanssen et al., 2015; Wright et al., 2016) . Three studies investigated long-term effects by focusing on an administration period between 6 days and 5 weeks Leidy et al., 2013; Rosenbaum et al., 2008) . As stated above, three studies did not administer any treatment Savage et al., 2014; Wallner-Liebmann et al., 2010) .
13 studies included obese participants beside healthy subjects Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014 Heni et al., , 2015 Hinkle et al., 2013; Jastreboff et al., 2016; Lennerz et al., 2013; Rosenbaum et al., 2008; Savage et al., 2014; Sun et al., 2015; Wallner-Liebmann et al., 2010; Zhang et al., 2015) , while 27 studies focused only on healthy controls De Silva et al., 2011; Douglas et al., 2015; Eldeghaidy et al., 2016; Goldstone et al., 2014; Jones et al., 2012; Karra et al., 2013; Kroemer et al., 2013a Kroemer et al., ,b, 2015 Lassman et al., 2010; Leidy et al., 2013; Li et al., 2012; Little et al., 2014; Liu et al., 2000; Malik et al., 2008; Page et al., 2009 Page et al., , 2011 Page et al., , 2013 Pannacciulli et al., 2007; Purnell et al., 2011; Schilling et al., 2014; Spetter et al., 2014; Sun et al., 2014; Tataranni et al., 1999; Wölnerhanssen et al., 2015; Wright et al., 2016) . Details are shown in Table 1 .
Effects of appetite-inducing hormones on the brain: ghrelin
Of the 10 fMRI studies investigating the effects of ghrelin on healthy subjects, four used a food cue paradigm ( Table 2 ). The 'food cue paradigm', also called "food-picture paradigm", refers to a block design in which high/low-energy-dense food pictures were shown in alternation to non-food pictures in a randomised fashion during the fMRI examination.
This approach was used for the first time by Malik et al. (2008) to investigate the effect of ghrelin on brain areas controlling appetite. After placebo (saline) administration, 0.5 mg/kg of ghrelin were injected with a peripheral venous cannula to 21 male healthy participants over a period of 20 min. In a food-cue paradigm, fMRI was performed during both the placebo and ghrelin conditions. Appetite scores were taken regularly during the blood-fMRI examination. Ghrelin increased the neural response to food pictures in different regions of the brain, including the amygdala, orbitofrontal cortex (OFC), anterior insula, and striatum, which are all implicated in encoding the incentive value of food cues. Moreover, the amygdala and OFC responses to ghrelin were positively correlated with subjects' self-rated hunger ratings. The relationship between enhanced levels of plasma ghrelin and corticolimbic activity is confirmed by a similar study of Goldstone et al. (2014) on 21 healthy participants receiving ghrelin or saline injection, in which increased OFC and hippocampus activity were observed after acute ghrelin administration. Furthermore, two overlapping fMRI studies of Kroemer et al. (2013a Kroemer et al. ( , 2015 using the same study population (26 healthy controls, 13 women) investigated how glucose and nicotine induced changes in ghrelin plasma levels and in brain responses during the presentation of food-related cues. In the first study , fMRI in a food-cue paradigm was performed after overnight fasting and after a standardised caloric intake (75 g of glucose). Fasting levels of ghrelin correlated positively with food-cue reactivity in the OFC and in the limbic and paralimbic regions, in which ghrelin receptors are densely concentrated. Moreover, fasting ghrelin levels were associated with an increase in subjective appetite.
In the second study , nicotine (2 mg) was administered to fasting subjects and after meal consumption. During fasting, nicotine administration weakened the correlations between ghrelin levels and brain activity in the mesocorticolimbic system (hypothalamus and nucleus accumbens). In contrast, after meal administration, nicotine increased the correlation between ghrelin plasma levels and activity in the ventromedial prefrontal cortex (vmPFC) and in the amygdala. These results confirm that nicotine affects how ghrelin modulates the neural responses of appetite.
Furthermore, five studies used an 'on-off treatment related block design' during fMRI examination to investigate the effects of ghrelin on brain areas controlling appetite and satiation. Nutrients are administered during the fMRI examination and the timing of ghrelin plasma absorption is used to investigate the brain response. This approach was used for the first time by Batterham et al. (2007) to investigate the effects of ghrelin on brain activity after placebo and PYY administration on eight healthy males. Ghrelin levels were negatively correlated with activation in the hypothalamus, ventral tegmental areas and brainstem after PYY administration. Furthermore, a negative correlation was shown between activity in these areas and satiety levels. These findings are confirmed by the study of Jones et al. (2012) using the same paradigm, in which an intravenous infusion of ghrelin (1.25 pmol/kg/min) was injected before and after intragastric administration of lipids (dodecanoate, C 12 ) to 20 healthy subjects. During digestion, a decrease in appetite was negatively correlated with activity in the midbrain, thalamus, hypothalamus, insula, amygdala and hippocampus.
Two studies using the same sample size ) investigated effects of ghrelin on 32 healthy individuals before and after meal ingestion using the same paradigm. During the fMRI examination, two different milkshake flavours (chocolate and strawberry) were administered. Larger post-prandial reductions in ghrelin plasma levels were associated with a reduced response to the chocolate milkshake in brain regions, including the midbrain, amygdala, pallidum, hippocampus, insula and medial OFC. Using the same paradigm, Li et al. (2012) investigated how ingested fat, glucose, protein, and water modulated brain activation in 14 healthy men. In line with previous findings , activation in the middle insula, amygdala and lateral OFC also correlated with changes in ghrelin levels after fat administration and glucose. Although this study did not demonstrate a direct correlation between cerebral activity and plasma ghrelin levels and appetite, it showed that ghrelin levels decreases after nutrient administration. Leidy et al. (2013) used fMRI to confirm these results, by exploring brain activation in response to food cues in 20 late adolescent girls who consumed either a normal protein breakfast, a high protein breakfast, or who skipped breakfast continuously for six days. In agreement with previous evidence, ghrelin plasma levels decreased after the high protein breakfast, and reduced activation was observed in the amygdala, hippocampus and para-hippocampus.
Finally one PET study focused on ghrelin and brain-related neurochemical changes . This study included 8 subjects of normal weight and 19 obese subjects and investigated midbrain dopaminergic neurons (DA type 2/type 3 receptor (D2/D3R)). In healthy individuals, fasting ghrelin correlated negatively with dopaminergic binding potential in the midbrain and nucleus accumbens.
3.4. Effects of glucose and satiety inducing hormones on the brain: glucose, insulin, peptide YY, leptin, GLP-1, and CCK • Standard breakfast, then a 90 min saline infusion (the fed saline visit).
• A 90 min PYY3-36 infusion at 0.3 pmol/ kg/min.
• A 90 min GLP-1 7-36 amide infusion at 0.8 pmol/kg/min.
• • Hinkle et al. (2013) • After a six weeks diet: • Post-prandial state:
1. Ghrelin bolus 2. Saline
• Fasting state:
• Ghrelin bolus (0.3 nmol/kg)
• Ghrelin injection • Lipid (dodecanoic acid, 250 mL)
• saline (control)
• CCK-1 receptor antagonist dexloxiglumide (600 mg orally)
• Lipid (dodecanoic acid, 250 mL)
• saline (control) • breakfast skipping
• cereal-based breakfasts:
13 g protein
• egg-and beef-rich breakfasts: 35 g protein
Food-cue 6 days Lennerz et al. (2013) • • Glucose • euglycemichypoglycemic (insulin)
• euglycemic-euglycemic • After a six weeks diet: (2013) 26 (13) 24.4 ± 3.4
18.5-24.9
Kroemer et al. (2013) 26 (13) 24.4 ± 3.5
18.5-24.10
Kroemer et al. (2015) 26 (13) 24.4 ± 3.6
18.5-24.11
Lassman et al. (2010) 19 Leidy et al. (2013) 19 ± 1 28.6 ± 0.7 Lennerz et al. (2013) 12 (12) 18-35
Li et al. (2012) 14 (14) 21-25
21.2
Little et al. (2014) Liu et al. (2000) 21 (11) 34 ± 3
Malik et al. (2008) 21 (21) 24.1 ± 1.1
22.3 ± 0.7 Neuroscience and Biobehavioral Reviews 80 (2017) [457] [458] [459] [460] [461] [462] [463] [464] [465] [466] [467] [468] [469] [470] [471] [472] [473] [474] [475] healthy subjects of glucose and satiety hormones on brain activation (Table 3) . Six studies investigated the effects of glucose plasma levels on the brain. In 2011, Page et al. (2011) administered glucose and insulin to induce a hypoglycaemic or euglycemic status in 21 healthy subjects. A food cue paradigm was used to investigate brain responses during these two conditions. Hypoglycaemia preferentially activated limbic-striatal brain regions (such as the insula, putamen, hypothalamus, caudate) in response to food cues to produce greater desire for high calorie food, while euglycemia preferentially activated the medial prefrontal cortex and resulted in less interest in food stimuli.
In the milestone fMRI study of Liu et al. (2000) , glucose was administered to 21 healthy volunteers in an 'on-off treatment related block design'. Temporal clustering analysis showed increased activation in the OFC, frontal lobe and decreased activation in the hypothalamus after glucose intake. Moreover, before glucose intake, plasma insulin levels correlated negatively with activity in the hypothalamus. Woelnerhanssen et al. (2011) used an RS paradigm to explore the effects of acute glucose and fructose administration on the connectivity within the basal ganglia network of 12 healthy participants. They found that after glucose and fructose administration, a glucose-induced increase in rsFC was present in the left caudatus, left putamen, precuneus and lingual gyrus and − relative to placebo − the glucose-induced increase in functional connectivity within the basal ganglia/limbic network correlated positively with glucose-induced insulin release. Wright et al. (2016) confirmed these results by showing that the connectivity between the left hypothalamus and the superior frontal gyrus was negatively correlated with glucose plasma levels during fasting sessions.
In a 2009 study on nine healthy subjects ), Page used an fMRI-ASL sequence to show that increases in glucose blood levels lead to regional increases in cerebral blood flow (CBF) in the cerebellum and decreases in the hypothalamus, inferior frontal gyrus, and anterior cingulate cortex. In a study of 2013 on 20 HC, the author confirmed the previous results. After a drink containing glucose or fructose, regional CBF was reduced within the hypothalamus, thalamus, insula, anterior cingulate, and striatum after glucose or fructose compared to baseline. Moreover, changes in the levels of plasma insulin correlated negatively with changes in regional CBF in the caudate and putamen in response to glucose ingestion.
Seven studies investigated the effects of insulin plasma levels on brain activity.
In a study conducted in 2013 (Kroemer et al., 2013b) , Kroemer used the "food cue paradigm" to investigate brain modifications after changes in insulin levels. fMRI was used to investigate reactivity to food cues after overnight fasting and following a standardised caloric intake (i.e., a 75 g oral glucose) in 26 participants. Increased plasma insulin levels correlated negatively with activity in the bilateral fusiform gyrus, superior temporal gyrus, medial frontal gyrus and the limbic system. In addition, activation in these regions was accompanied by lower subjective appetite ratings. In the same line, Wallner-Liebmann et al. (2010) showed that during high caloric food cues, insulin levels are positively associated with hippocampal activity and negatively with activity in the right superior frontal gyrus and left thalamus in 12 healthy adolescents.
Using an 'on-off treatment related block design' in a study on 14 healthy subjects, Li et al. (2012) showed that levels of plasma insulin after glucose administration correlated negatively with activity in the middle insula, thalamus, amygdala and lateral OFC, and -after protein administration -with activity in the caudate. In the same line, in the study of Purnell et al. (2011) on nine healthy individuals, increased activation in the OFC and increases in plasma glucose and insulin levels were observed during glucose infusion. Spetter et al. (2014) demonstrated that insulin responses following naso-gastric infusion of chocolate milk to 16 healthy individuals correlated positively with brain activation in the anterior cingulate cortex (ACC) and putamen and (2014) 16 (16) 24.6 ± 3.8
22.3 ± 1.6
Sun et al. (2014) 32 (14) 25.5 ± 5.7
25.3 ± 4.4
Sun et al. (2015) 20 (9) 26 ± 5.9
21.7 ± 1.4
13 (7) 28.2 ± 6.6
28.1 ± 2.5 Tataranni et al. (1999) 11 ( 
12 (6) 18.3 ± 3.4 20.9 ± 1.6
12 (6) 18.0 ± 3.7
34.1 ± 5.6
Wölnerhanssen et al.
12 (12) 24.8
22.9
Wright et al. (2016) 19 (9) 24.8 ± 3.8 < 30
Zhang et al. (2015) 20 (20) 18.5-23.9
20 (20) > 28 Neuroscience and Biobehavioral Reviews 80 (2017) 457-475 • Effects of ghrelin on C12-induced BOLD signal:
1. In the midbrain, pons and hypothalamus, ghrelin blocked the increase in BOLD signal in response to C12, and in the insula and amygdala/hippocampus the C12 response was reduced by ghrelin to baseline Karra et al. Finally, one study used PET to investigate the effects of insulin plasma changes on brain activity. Tataranni et al. (1999) investigated brain neurochemical changes after satiation (liquid meal intake) or in the fasting state in 11 healthy subjects. Satiation was associated with increased CBF in the ventromedial prefrontal cortex, dorsolateral prefrontal cortex, and inferior parietal lobule. Furthermore, changes in plasma insulin concentrations in response to the meal were negatively correlated with changes in CBF in the insular and OFC.
A recent study of Kromer, as previously discussed , used fMRI to investigate effects of leptin on food-cue reactivity before and after a caloric load (oral glucose tolerance test, OGTT) in 26 healthy normal weight never-smokers. During fasting, nicotine administration increased correlations between leptin levels and activation in the mesocorticolimbic system. After the OGTT, nicotine increased the effects of leptin on food-induced neural activity, positively correlating with activity in the ventromedial prefrontal cortex (vmPFC) and the amygdala. Nicotine therefore enhances the effect of leptin, which might in turn reduce appetite.
Five studies investigated the effects of PYY and GLP-1 plasma levels on the brain.
De , using the "food cue paradigm" during fMRI examination, and demonstrated that PYY and GLP-17-36 administration to 16 healthy subjects reduced appetite and in turn altered brain activity was present in areas as the amygdala, caudate, insula, nucleus accumbens, OFC and putamen. Similar findings were also found in the study of Leidy, as previously described , which demonstrated that increased PYY plasma concentrations were negatively correlated with activity in the amygdala, hippocampal and para-hippocampal areas. Douglas et al. (2015) confirmed these results, using the same paradigm, and showed that high protein meal (beef lunch) increased GLP-1 and PYY3-36 plasma levels and in turn reduced activity in the anterior cingulate and insula in 21 healthy subjects. Moreover, GLP-1 levels correlated negatively with activation in the middle insula and lateral OFC after both glucose and protein administration. On the contrary, Batterham et al. (2007) , using the 'on-off treatment related block design', showed that with high plasma PYY concentrations, mimicking the fed state, there was increased neural activity in the caudolateral OFC (as insula and anterior cingulate cortex).
In a fMRI-ASL on 42 healthy participants, Pannacciulli et al. (2007) showed that, in the postprandial state, there was an increased plasma concentration of GLP-1, which was positively correlated with increased rCBF in the left dorsolateral prefrontal cortex (including the left middle and inferior frontal gyri) and hypothalamus.
Finally, four studies investigated CCK effects at the brain level. A study previously reported by Li et al. (2012) using an 'on-off treatment related block design' on 14 healthy subjects, showed that levels of plasma CCK after glucose administration correlated negatively with activity in the caudate and in the thalamus. Moreover, in a work of Eldeghaidy on 17 healthy adults, an fMRI examination was performed assessing how prior consumption of an HFM or water load modulates reward, homeostatic, and taste brain responses to the subsequent delivery of oral fat. Their findings show that an individual's plasma CCK concentration correlated negatively with brain activation in taste and oral somatosensory areas, insula, amygdala and thalamus. A similar study of Little et al. (2014) administering to 12 healthy subjects an intragastric infusion (250 mL) of 1 M glucose and predosing with dexloxiglumide (CCK receptor antagonist) or 1 M glucose + placebo, or 0.9% saline (control) + placebo, highlighted a CCK1-receptor 
PET ROIs (substantia nigra) Correlations P < 0.05
○ Substantia nigra↑
• Obese:
• no correlation Sun et al. (2014) Table 3 Effects of satiety inducing hormones and nutrients on the brain: glucose, insulin, peptide YY, leptin and GLP-1. Decreased activation:
"↓". Increased activation:
"↑".
Authors and year of publication ○ Anterior cingulate cortex↑ Putamen↑ Insula ↓ (continued on next page) dependent increase in Blood oxygenation level dependent (BOLD) signal in the motor cortex. Lastly, a study of Lassman et al. (2010) , investigating the brain activation responses to ingested lipid (dodecanoic acid) or saline (control) on 19 healthy subjects with and without prior administration of the CCK receptor antagonist dexloxiglumide, showed significant interaction of dexloxiglumide before treatment on brain stem, hypothalamus, precuneus, cingulate cortex, temporal gyrus and caudate.
The main areas involved in the neural circuit of appetite and target of the gut peptides are shown in Fig. 2. 3.5. Effects of gut peptides on the brain in patients with obesity 13 of the included studies focused on the neural effects of gut peptides in obese subjects Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014 Heni et al., , 2015 Hinkle et al., 2013; Jastreboff et al., 2016; Lennerz et al., 2013; Rosenbaum et al., 2008; Savage et al., 2014; Sun et al., 2015; Wallner-Liebmann et al., 2010; Zhang et al., 2015) . Three studies were conducted to test the effects of ghrelin on brain areas of obese subjects in comparison to lean subjects Karra et al., 2013; Savage et al., 2014) . Karra et al. (2013) investigated the relation between changes in plasma ghrelin concentrations and obesity, focusing on the obesity-associated gene (FTO). This fMRI study examined how brain responses to food cues differed between 12 carriers of the AA genotype and 12 carriers of the TT allele after consumption of a standard meal. During the fasted state, activation in the hypothalamus, nucleus accumbens, cingulate gyrus and OFC correlated positively with ghrelin levels in the AA group and with greater feelings of hunger. These results show that the FTO gene and ghrelin are key mediators of ingestive behaviour. Jastreboff et al. (2016) tested how glucose and fructose administration modulated brain perfusion in 14 lean and 24 obese subjects. Obese patients showed high levels of perfusion in the hypothalamus and thalamus that was related to high plasma concentrations of ghrelin, while low levels of perfusion in the prefrontal cortex and anterior cingulate cortex were linked to low plasma levels of ghrelin Savage et al., 2014) . Furthermore, Savage and colleagues found different brain responses between lean and obese subjects with respect to ghrelin plasma levels . Using positron emission tomography (PET) imaging, they investigated the expression of DA type 2/t 3 receptors (D2/D3R) in eight subjects with normal weight compared to 19 obese subjects. Ghrelin levels and D2/D3R binding potential (BPND) in the substantia nigra were positively D. Zanchi et al. Neuroscience and Biobehavioral Reviews 80 (2017) 457-475 correlated in normal weight but not in obese participants. On the other hand, 11 studies investigated differences in brain activation in obese subjects compared to lean subjects in relation to changes in glucose and satiety hormones Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014 Heni et al., , 2015 Hinkle et al., 2013; Jastreboff et al., 2016; Karra et al., 2013; Lennerz et al., 2013; Rosenbaum et al., 2008; Zhang et al., 2015) . In one study, both ghrelin and insulin were measured . Lennerz et al. (2013) focussed on glucose plasma levels and explored resting state connectivity in 12 overweight men after a high glycaemic (high GI) or a low glycaemic meal (low GI). Compared with a low GI meal, a high GI meal decreased plasma glucose, increased hunger and enhanced activation in the nucleus accumbens, striatum and olfactory area. Heni et al. (2014 Heni et al. ( , 2015 explored the effects of glucose ingestion on brain activity in 12 lean and 12 obese subjects, using a fMRI food-induced paradigm. The hypothalamic response to high caloric food cues correlated negatively with changes in blood glucose levels 30 min after glucose ingestion, while activation in the ACC and OFC correlated negatively with increased plasma insulin levels 120 min after glucose ingestion. These effects can be observed in both the obese and lean groups. In a similar study, Jastreboff et al. (2016) , confirmed these results, by showing that obese adolescents exhibited decreased CBF in the PFC, striatum and hypothalamus after drinking glucose. The hippocampus, an area implicated in the processing of high caloric food pictures, was also identified by Wallner-Liebmann et al. (2010)), which found a positive correlation between hippocampus activity and waist circumference.
Insulin-related brain changes were also investigated by Gautier et al. (2000) in a study on 11 lean and 11 obese subjects, that combined PET and fMRI-ASL sequences after fasting or satiation (liquid meal). A converse correlation was found between changes in plasma insulin concentrations and changes in rCBF in the precuneus, orbitofrontal cortex, putamen and thalamus in obese and lean subjects. This study raises the possibility that activation in OFC (involved in the inhibition of inappropriate response tendencies) and limbic/paralimbic areas (associated with the regulation of emotion) during eating may be different in obese and lean men.
As regards leptin, and using fMRI in a food cue paradigm, Grosshans et al. (2012) showed that plasma leptin levels were associated with brain activation in the ventral striatum and with BMI in 21 obese subjects. According to this study, leptin is therefore a satiety hormone linked to increased activation in subcortical regions and to weight gain.
In the same line, and with fMRI in a food-cue paradigm, Rosenbaum et al. (2008) examined how brain responses to food cues were modulated after subcutaneous injection of leptin in six obese subjects following a diet. During weight loss, leptin-related increases in neural activity in response to visual food cues were observed in the brain stem, parahippocampal gyrus, inferior and middle frontal gyri, middle temporal gyrus, and lingual gyrus. Leptin-related decreases were observed in the hypothalamus, cingulate gyrus, and middle frontal gyrus.
A recent study by Hinkle et al. (2013) confirms these results and investigated changes in the connectivity of the right hypothalamus in respect to leptin plasma levels in 10 obese subjects. Using fMRI with a food cue paradigm, the functional connectivity of the right hypothalamus with the mid-insula and the central and parietal operculae increased after leptin injections, while it decreased with the OFC, frontal pole and the dorsal ACC.
Apart from insulin, effects of changes in GLP-1 plasma levels on the brain have also been investigated in obese subjects. van Bloemendaal et al. (2014) explored how the administration of the GLP-1 receptor agonist exenatide modulated brain responses to food pictures during a somatostatin pancreatic-pituitary clamp in 16 obese and 16 normalweight subjects. Relative to lean subjects, obese subjects showed increased brain responses to food pictures in the insula, amygdala, putamen, and OFC. In the same line, in a second study performed in 2015, Heni et al. (2015) administered 75 g of glucose to promote GLP-1 secretion. Food cue-induced brain activity was assessed with fMRI and GLP-1 concentrations measured before, 30 and 120 min after glucose intake. The significant increase in GLP-1 levels correlated negatively with a change in the food cue-induced brain activity in the OFC in lean and overweight participants. In contrast, postprandial changes in plasma insulin were associated with OFC activations in lean individuals only. Finally, using rsfMRI, Zhang et al. (2015) investigated the amplitude of low frequency fluctuations of spontaneous signals during both hunger and satiety states in 20 lean and 20 obese males. Before food intake, obese men had significantly higher baseline activity in the precuneus and lower activity in the dorsal anterior cingulate cortex (dACC) relative to lean subjects. After food intake, obese males had significantly lower activity in the dorsal anterior cingulate cortex (dACC) than lean males. Moreover a significant positive correlation was found between precuneus activation and hunger ratings before food intake, while dACC activity was negatively correlated with plasma insulin levels before and after food intake in both groups. These results indicated that both precuneus and dACC may play an important role in eating behaviour. While precuneus seemed to mediate subjective satiety, dACC activation rather reflected indirect measures of glucose utilisation.
Discussion
To our knowledge, this is the first study to systematically review the effects of different gut peptides on brain activation in healthy and obese subjects. Forty original studies were retrieved, which addressed how key gut hormones or nutrients, such as ghrelin, glucose, insulin, leptin, PYY, GLP-1 and CCK, modulate functional brain activation after food intake. Plasma levels of the appetite-promoting gut hormone ghrelin positively correlate with activity in the PFC, amygdala and insula and negatively correlate with activity in subcortical areas such as the hypothalamus. In contrast, satiety-regulating gut hormones or nutrients like glucose, insulin, letpin, PYY, GLP-1 and CCK affect the same brain regions in the opposite directions. Nevertheless, the lack of reproducible studies and the existence of multiple methodological approaches prevent definitive conclusions and explains some discrepancies in the results between the different studies. The present review is to be considered as the basis for a future meta-analysis of brain-gut interactions.
nutrients were ingested orally Eldeghaidy et al., 2016; Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014 Heni et al., , 2015 Jastreboff et al., 2016; Karra et al., 2013; Kroemer et al., 2013a Kroemer et al., ,b, 2015 Leidy et al., 2013; Lennerz et al., 2013; Li et al., 2012; Liu et al., 2000; Page et al., 2013; Pannacciulli et al., 2007; Savage et al., 2014; Spetter et al., 2014; Sun et al., 2014 Sun et al., , 2015 Tataranni et al., 1999; Wallner-Liebmann et al., 2010; Wright et al., 2016; Zhang et al., 2015) . Oral intake aimed to mimic the consumption of daily meals, whereas intragastric/intravenous administration aimed to directly assess the effects of the target hormones. The difference in the acquisition procedure leads to two main consequences in the comparison of the studies: a) intragastric/intravenous administration could lead to uncomfortable feelings and therefore influence data acquisition, b) differences in the timing of nutrient absorption leads to differences in the timing of the fMRI examination (immediately after nutrient administration or after 10, 30, 120 min).
Differences in the paradigm during the fMRI examination
Different paradigms were used during the neuroimaging examination to investigate the effects of gut peptides on brain activation. 16 studies De Silva et al., 2011; Douglas et al., 2015; Goldstone et al., 2014; Grosshans et al., 2012; Heni et al., 2014 Heni et al., , 2015 Hinkle et al., 2013; Karra et al., 2013; Kroemer et al., 2013a Kroemer et al., ,b, 2015 Leidy et al., 2013; Malik et al., 2008; Page et al., 2011; Rosenbaum et al., 2008; Wallner-Liebmann et al., 2010) used a "foodcue paradigm" to investigate effects of gut peptides on feelings of appetite and neural activity during high and low caloric food cues. The "food-cue paradigm" refers to a block design in which high/low energy dense food pictures were shown alternatively to non-food pictures in a randomised fashion during the fMRI examination.
On the other hand, 9 studies Eldeghaidy et al., 2016; Jones et al., 2012; Li et al., 2012; Liu et al., 2000; Purnell et al., 2011; Spetter et al., 2014; Sun et al., 2014 Sun et al., , 2015 used an 'on-off treatment related block design' to assess the direct effect of the target compound on the brain. Nutrients are administered during the fMRI examination and the timing of hormonal plasma absorption is used to investigate the brain response. The best example is a milestone study by Liu et al. (2000) , in which the statistical model to investigate the BOLD signal is based on the increasing insulin plasma levels after glucose administration. The last paradigm used during fMRI examination was that of the classical resting state. At the highest point of plasma hormone absorption, an fMRI sequence is performed; the subjects had to relax and not think about anything in particular. Differences within brain networks involved in appetite and satiety regulation were then investigated.
Although these paradigms are different, the absence of any cognitive tasks makes the results rather comparable. The focus is on brain activity changes associated with variations in hormonal plasma concentrations.
Neuroimaging results
In line with subjective feelings of appetite, neuroimaging results demonstrate that the two classes of gut hormones have opposite effects on the neural circuit of appetite. In particular, activation in frontocortical regions, such as OFC, ACC and insula correlates positively with ghrelin plasma levels, and with increased hunger feelings. Subcortical areas like the thalamus, hippocampus, striatum and hypothalamus correlated negatively with ghrelin levels. These results have consistently been reported in 8 studies Goldstone et al., 2014; Jones et al., 2012; Kroemer et al., 2013a Kroemer et al., , 2015 Li et al., 2012; Sun et al., 2014 Sun et al., , 2015 , while 2 studies Savage et al., 2014) found associations in different directions. This discrepancy can perhaps be explained by the use of the food-cue paradigm that could discriminate between high caloric and low caloric food cues and therefore be more specific.
In contrast, plasma levels of satiety-stimulating hormones correlate negatively with the same cortical areas and positively with subcortical areas.
The present findings fit with a model proposed by Woods (Woods et al., 1998) , which embeds gut-brain interactions during food-intake within the framework of homeostasis regulation. After food intake, the circulating adipose signals (ghrelin and insulin) penetrate the blood brain barrier and stimulate receptors on neurons in the hypothalamus (Woods et al., 1998) . Satiety signals generated by ingested food enter subcortical areas, such as amygdala and striatum, where they influence reflexes related to the acceptance or rejection of food. In a second step, the hypothalamus sends signals to cortical areas, such as the OFC, ACC and insula, as part of the reward mechanism, where cognitive information is integrated with adiposity signals. A higher cognitive evaluation is performed and the prospective eating behaviour is determined. This model of integration between gut peptides, brain responses and subjective feelings explains the opposite direction of the correlations between cortical and subcortical brain activation, subjective satiety and appetite feelings and hormonal plasma levels.
Increased activity of adiposity signals enhances the ability of satiety signals to terminate a meal or of appetite signals to continue eating.
Although this pattern is clear in the majority of the included studies Douglas et al., 2015; Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014 Heni et al., , 2015 Hinkle et al., 2013; Jastreboff et al., 2016; Kroemer et al., 2013b Kroemer et al., , 2015 Lennerz et al., 2013; Li et al., 2012; Page et al., 2013; Rosenbaum et al., 2008; Spetter et al., 2014, p. 20; Tataranni et al., 1999; Wright et al., 2016; Zhang et al., 2015) , discrepancies across studies may be due to the peculiarity of the different satiety stimulating hormones that have intrinsic properties and therefore affect different brain areas in different ways.
Differences between a clinical obese and a healthy lean population
Finally, our last result concerns the effects of gut peptides on brain activation in obese subjects. The included studies provide little, if any, evidence for alterations in obese compared to lean subjects. In particular, the results of gut hormones on brain regional activity in the obese population is not reproduced by any study using the same amount of ingested nutrients and the same paradigm. Moreover, it is very hard to compare brain changes in obese and lean subjects due to a lack of statistical comparisons between the two groups within each study.
Moreover, the discrepancies of results can be explained by methodological issues (the different nutrients administered, different peptides investigated and different paradigms used during the fMRI examination) and by the low number of studies performed and the lack of reproducibility of the results. Further investigations on the differential effects of gut peptides on the appetite circuit between obese and lean population are therefore needed.
Limitations
A first limitation that we want to highlight is that most studies didn't control for possible pre-existing preferences for the participants for certain type of foods and this can impact the studies results. Moreover, the results might be influenced by psychopathological states, such as mood disturbances, which have not been systematically assessed in the included studies. Also the use of cannabinoids or psychoactive substances was self-reported and consequently not necessarily accurate (Becker et al., 2015) . These factors may confound the neuroimaging results.
The amount of nutrients ingested varied in several studies and this hampers comparability. Moreover, the timing of the fMRI examination was very different across studies. It varied from an examination immediately after substance intake to 6 weeks post-administration. Although (as stated above) the timing was in accordance with the aim of the investigation, it cannot be denied that this may result in a confounding factor and make the studies poorly comparable. Furthermore, in neuroimaging studies addressing brain-gut interactions in healthy subjects, the sample sizes were modest because the design of the study makes recruitment of subjects relatively difficult.
Finally, we suggest that studies including randomised samples that express preferences for specific food have to be conducted. Moreover, psychopathological states, such as mood disturbances in the participants, have to be previously screened in order to avoid confounding factors that can affect the results. Furthermore, studies on eating disorders, such as anorexia and bulimia, can greatly enhance the clinical relevance of studies of the effects of specific nutrients on brain regions regulating appetite. It would also be interesting to investigate cognitive changes (such as working memory performance) after nutrient administration, as shown by pioneering studies (Borgwardt et al., 2012; Schmidt et al., 2014) .
Finally, studies using a standardised amount of ingested nutrient should be performed, since the amount of ingested nutrients can also lead to differences in the strength of brain activation
Conclusion
The present article systematically reviewed the existing literature investigating how gut peptides influence brain regions regulating appetite and satiety in healthy and obese subjects. The activation of brain areas controlling the brain-gut matrix occurs in opposite directions in respect to satiety or appetite regulation. The present review can enhance our understanding of the physiology of eating behaviour and the pathophysiology of obesity and eating disorders and is the basis for a future meta-analysis in the field.
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